<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000316080"><TermName>pegfilgrastim</TermName><TermPronunciation>(peg-fil-GRAS-tim)</TermPronunciation><TermDefinition><DefinitionText>A drug used to increase numbers of white blood cells in patients who are receiving chemotherapy. It is a type of colony-stimulating factor. Also called filgrastim-SD/01 and Neulasta.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000711297" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;pegfilgrastim&quot;" language="en" id="_3"/><MediaLink ref="CDR0000711296" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;pegfilgrastim&quot;" language="es" id="_4"/><SpanishTermName>pegfilgrastim</SpanishTermName><SpanishTermDefinition><DefinitionText>Medicamento que se usa para aumentar el número de glóbulos blancos de los pacientes que reciben quimioterapia. Es un tipo de factor estimulante de colonias. También se llama filgrastim-SD/01 y Neulasta.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2003-06-23</DateFirstPublished><DateLastModified>2007-04-12</DateLastModified></GlossaryTerm>
